Biology:TFCP2

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

Alpha-globin transcription factor CP2 is a protein that in humans is encoded by the TFCP2 gene.[1][2]

TFCP2 is also called Late SV40 factor (LSF) and it is induced by well known oncogene AEG-1.[3] LSF also acts as an oncogene in hepatocellular carcinoma.[4] LSF enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP9).[5]

Along with its main oncogene function in hepatocellular carcinoma (HCC) it plays multifaceted role in chemoresistance, epithelial-mesenchymal transition (EMT), allergic response, inflammation and Alzheimer's disease.[4][6] The small molecule FQI1 (factor quinolinone inhibitor 1) prevents LSF from binding to HCC DNA which results in HCC cell death.[4][6][7]

Interactions

TFCP2 has been shown to interact with APBB1[8] and RNF2.[9]

References

  1. "Characterization of the genomic structure, chromosomal location, promoter, and development expression of the alpha-globin transcription factor CP2". The Journal of Biological Chemistry 269 (15): 11663–71. Apr 1994. doi:10.1016/S0021-9258(19)78176-9. PMID 8157699. 
  2. "Entrez Gene: TFCP2 transcription factor CP2". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7024. 
  3. "Identification of genes conferring resistance to 5-fluorouracil". Proceedings of the National Academy of Sciences of the United States of America 106 (31): 12938–43. Aug 2009. doi:10.1073/pnas.0901451106. PMID 19622726. Bibcode2009PNAS..10612938Y. 
  4. 4.0 4.1 4.2 "Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma". Proceedings of the National Academy of Sciences of the United States of America 107 (18): 8357–62. May 2010. doi:10.1073/pnas.1000374107. PMID 20404171. Bibcode2010PNAS..107.8357Y. 
  5. "Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9)". The Journal of Biological Chemistry 287 (5): 3425–32. Jan 2012. doi:10.1074/jbc.M111.298976. PMID 22167195. 
  6. 6.0 6.1 "The transcription factor LSF: a novel oncogene for hepatocellular carcinoma". Am J Cancer Res 2 (3): 269–285. 2012. PMID 22679558. PMC 3365805. http://www.ajcr.us/files/ajcr0000110.pdf. 
  7. "Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma". Proceedings of the National Academy of Sciences of the United States of America 109 (12): 4503–8. Mar 2012. doi:10.1073/pnas.1121601109. PMID 22396589. Bibcode2012PNAS..109.4503G. 
  8. "The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1". The Journal of Biological Chemistry 273 (32): 20128–33. Aug 1998. doi:10.1074/jbc.273.32.20128. PMID 9685356. 
  9. "Binding of the RING polycomb proteins to specific target genes in complex with the grainyhead-like family of developmental transcription factors". Molecular and Cellular Biology 22 (6): 1936–46. Mar 2002. doi:10.1128/MCB.22.6.1936-1946.2002. PMID 11865070. 

Further reading